Navigation Links
InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
Date:9/13/2010

InterMune has an R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes pirfenidone for which InterMune has completed the Phase 3 CAPACITY program in patients with IPF. A Marketing Authorization Application (MAA) for pirfenidone is under review by the European Medicines Agency (EMA). The hepatology portfolio includes the HCV protease inhibitor compound danoprevir (also known as RG7227 and ITMN-191) that entered Phase 2b in August 2009 and a second-generation HCV protease inhibitor research program. For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, which reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to anticipated regulatory timelines and the likelihood of regulatory success. All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information. InterMune's actual results could differ materially from those described in InterMune's forward-looking statements. Pirfenidone failed to achieve statistical significance on the primary endpoint in one of its two pivotal clinical trials and there can be no assurance that the regulatory authorities in either the United States or Europe will grant regulatory approval based upon these data, in combination with the other efficacy and safety results the company has submitted in support of its New Drug Application (NDA) and MAA filings. Furthermore, while the Pulmonary-Allergy Drugs Advisory Commi
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune to Release Second Quarter Financial Results on July 27
2. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
3. FDA Advisory Committee Recommends Approval of InterMunes Esbriet(R) (pirfenidone) for Idiopathic Pulmonary Fibrosis
4. InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
5. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
6. InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
7. InterMune to Present at Deutsche Bank Biotech Confab
8. InterMune Reports Third Quarter 2009 Financial Results and Business Highlights
9. InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF
10. InterMune to Present at JMP Securities Conference
11. InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  Vermillion, Inc. (NASDAQ: ... gynecologic cancers and women,s health, has appointed Holly ... Managed Markets. Ms. Bauzon has a proven ... payer coverage for laboratory services companies. She has more ... PerkinElmer, Inc., where she held the position of Director, ...
(Date:8/21/2014)... , Aug. 21, 2014  eRelevance Corporation ... company, announced today that it has completed integration ... solution for Plastic Surgery and Dermatology practices. ... more value to healthcare practices using Nextech," stated ... eRelevance Corporation. "Using information from the EMR we ...
(Date:8/21/2014)... 21, 2014  Publicis Groupe customer engagement agency ... Partner and Healthcare Industry Group Leader, has been featured ... the most inspiring people in the life-sciences industry. Those ... and development, marketing, technology, creativity, strategy and medicine. ... a partner in its leading Rosetta Consulting practice. In ...
Breaking Medicine Technology:Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Shannon Hartley Shines in PharmaVOICE 100 2
(Date:8/22/2014)... August 22, 2014 Until now, those with ... crutches or walkers to keep mobile. Thanks to an inventor ... much more effective. , He developed a prototype for the ... injured leg or foot but provide comfort and reduce pain ... different heights, it is also convenient and easy to install ...
(Date:8/22/2014)... a wide range of epigenetic changesalterations in DNA across the ... with Crohn,s disease (CD), reports Inflammatory Bowel Diseases ... Foundation of America (CCFA). The journal is published ... Wolters Kluwer Health . , The study ... of the genome in children with CD, according to Professor ...
(Date:8/22/2014)... lymphoma will be able to better understand their risks ... premature menopause with different treatments. , The findings, set ... Institute , are based on the experience of more ... for the cancer over a period of more than ... with Hodgkin lymphoma who receive certain types of chemotherapy ...
(Date:8/22/2014)... Watertown, MA (PRWEB) August 22, 2014 ... Health (IFNH) at Rutgers, the State University of ... , an innovative children’s media organization, to educate young ... that will build on the strengths of both organizations. ... ChopChop Magazine, a health communications fellowship program, and video ...
(Date:8/22/2014)... Ticket Down is a reliable source for cheap ... Rentschler Field. There has never been a better time to be ... After the strong showing at the 2014 World Cup in Brazil, ... featured in large stadiums around the country. Since the World Cup ... some of the best club teams in the sport played on ...
Breaking Medicine News(10 mins):Health News:Assistive Device for Walking Invented by InventHelp Client (VBL-501) 2Health News:Study shows epigenetic changes in children with Crohn's disease 2Health News:Scientists map risk of premature menopause after cancer treatment 2Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 2Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 3Health News:USA vs. Ecuador Tickets: Ticket Down Slashes USA (USMT) vs. Ecuador Tickets at Rentschler Field in East Hartford on Oct. 10th 2Health News:USA vs. Ecuador Tickets: Ticket Down Slashes USA (USMT) vs. Ecuador Tickets at Rentschler Field in East Hartford on Oct. 10th 3
... review investigating the effectiveness of a publicly funded graphic ... been associated with many negative outcomes. The review ... Science , a peer reviewed journal of the Society ... was created in 2005 to reduce methamphetamine use in ...
... or the "Company"), a leading provider of laser vision,correction services under the LasikPlus(R) ... stockholders in response to,recent letters from those stockholders to the Board. , ... Company,s Board of Directors appears,below: , , ... December ...
... Visit Atlantic City , , ATLANTIC CITY, ... who had been wounded in the Iraq conflict and recuperating at Walter ... a visit to Harrah,s Resorts in Atlantic City. , ... women, recovering , from war injuries and wishing for the ...
... N3 Oceanic, Inc. announced the addition of Orosine to ... cardiologist Dr. Jeffrey Shapiro, MD, Assistant Professor of Internal ... Langone Medical Center, who has been giving the formula to ... Dr. Shapiro states, Orosine is the most significant natural product ...
... Precision Optics,Corporation, Inc., (OTC Bulletin Board: POCI) ... the company,s common stock. Stockholders approved,the reverse split ... 2008. The,Board of Directors has determined that the ... Precision Optics Corporation and its stockholders, providing,the benefits ...
... are not being provided in Zimbabwe. The public health system ... Staggering inflation and unemployment have resulted in shortages of food ... of cholera, which is being spread by a shortage of ... date, the outbreak has claimed over 600 lives. , ...
Cached Medicine News:Health News:Success of anti-meth ads questioned by study 2Health News:Success of anti-meth ads questioned by study 3Health News:LCA-Vision Board of Directors Responds to Recent Letters from Stockholder Group 2Health News:LCA-Vision Board of Directors Responds to Recent Letters from Stockholder Group 3Health News:LCA-Vision Board of Directors Responds to Recent Letters from Stockholder Group 4Health News:Wounded Warriors to be Holiday Guests of Harrah's Entertainment 2Health News:Res-Q Gains Rights To Market Orosine - a Breakthrough, Patented, Natural Heart Supplement That Cardiologists Are Calling the 'Ultimate Cardio Protection' Against Heart Attacks, Strokes and Heart Failure. 2Health News:Precision Optics Corporation to Effect Reverse Split and Ticker Symbol Change 2
... Medical is the world leader in ... used worldwide for permanent pacemaker and ... and port implantation, and for temporary ... St. Jude Medical Peel-Away introducers includes ...
... Self-Expanding Stent System combines low-profile, high radial force, ... guide wire compatible stent system provides 6F sheath ... (5.0 - 10.0 mm). Now, with longer stents ... five stent lengths (28, 38, 56, 80 and ...
... A particular challenge in transseptal left heart ... must be exchanged for a sheath with ... wall position. Traditionally, such an exchange has ... heparinized patient. Biosense Webster has overcome this ...
Coaxial Multicolor LIO Worlds first coaxial multicolor LIO provides precise laser delivery with repeatable outcomes, as well as maximum treatment options and physician safety....
Medicine Products: